GPCRs: Ligands and Beyond 2023
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 431
Special Issue Editors
Interests: vitamin A and its provitamin; microRNAs; gene expression; ketogenic diet; lipedema; cognitive and neurodegeneration
Special Issues, Collections and Topics in MDPI journals
Interests: immune system; pharmacology; cell signaling; COVID 19
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, tremendous progress has been seen in elucidating experimental structural information for G-protein coupled receptors (GPCRs). Mainstream, pharmaceutically relevant GPCR structural information is accessible by homology models that progressively increase the structural information. This has fostered the application of structure-based drug design tools for this emerging class of drug targets. Likewise, the discovery of natural compounds and/or endogenous ligands molecules on GPCRs has remained a largely unexplored research subject. GPCR topics of interest include: i) expression; ii) signaling; iii) molecule interaction; iv) molecular dynamics; and v) docking in physiological and pathophysiological models. Therefore, considering the success of the first volume of this Special Issue, we decided to generate a sequel to support further research.
Prof. Dr. Erika Cione
Dr. Maria Cristina Caroleo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
